Lind Global Fund II LP 13D and 13G filings for Revelation Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 8:12 pm Purchase |
2023-12-31 | 13G | Revelation Biosciences, Inc. REVB |
Lind Global Fund II LP | 11,656 2.900% |
11,268 (+2900.00%) |
Filing |
| 2023-02-21 4:49 pm Purchase |
2023-02-13 | 13G | Revelation Biosciences, Inc. REVB |
Lind Global Fund II LP | 389 5.200% |
389 (New Position) |
Filing |